- Apyx Medical Corporation (APYX, Financial) to release Q1 2025 financial results on May 8, 2025.
- Conference call scheduled for the same day at 8:00 a.m. Eastern Time.
- Renuvion® and J-Plasma® technologies supported by over 90 clinical publications.
Apyx Medical Corporation (APYX), a leader in advanced energy technology, has announced that it will release its financial results for the first quarter of fiscal year 2025 before market open on May 8, 2025. The company, known for its proprietary helium plasma and radiofrequency technology, Renuvion®, will provide a detailed overview of the fiscal quarter's performance.
Management will host a conference call at 8:00 a.m. Eastern Time on the same day to discuss the financial results and answer questions from participants. Interested individuals can join the call by dialing 800-717-1738 for domestic calls or 646-307-1865 for international calls, using access code 63341. Alternatively, the webcast will be accessible via the Apyx Medical Investor Relations section on their website.
The company's flagship products, Renuvion® for cosmetic surgery and J-Plasma® for hospital surgical markets, leverage their Helium Plasma Platform Technology. These technologies offer surgeons the ability to apply controlled heat to tissue, with their efficacy supported by more than 90 clinical publications.
For additional details on Apyx Medical’s products and initiatives, as well as to access the webcast link, visit the company's official website at www.ApyxMedical.com.
